{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:52:54Z","timestamp":1718466774128},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Excision repair cross-complementing group 2<\/jats:italic> (<jats:italic>ERCC2<\/jats:italic>) plays important roles in the repair of DNA damage and adducts. Single nucleotide polymorphisms (SNPs) of <jats:italic>ERCC2<\/jats:italic> gene are suspected to influence the risks of oral cancer. We performed a meta-analysis to systematically summarize the possible association of <jats:italic>ERCC2<\/jats:italic> rs1799793 and rs13181 polymorphisms with oral cancer risks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrieved the relevant articles from PubMed and Embase databases. Studies were selected using specific criteria. ORs and 95% CIs were calculated to assess the association. All analyses were performed using the Stata software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Six studies were included in this meta-analysis. There were no significant associations between <jats:italic>ERCC2<\/jats:italic> rs1799793 and rs13181 polymorphism with overall oral cancer risk. In the stratified analysis by ethnicity, no significant associations were found. In the stratified analysis by tumor type, the risk of oral leukoplakia was significant associated with rs13181 polymorphism (AC vs. AA: OR = 1.28, 95% CI = 1.01-1.62, P = 0.546 for heterogeneity, I<jats:sup>2<\/jats:sup> = 0.0%; CC vs. AA: OR = 1.94, 95% CI = 0.99-3.79, P = 0.057 for heterogeneity, I<jats:sup>2<\/jats:sup> = 60.1%; dominant model AC\u2009+\u2009CC vs. AA: OR = 1.35, 95% CI = 1.08\u20131.69, P = 0.303 for heterogeneity, I<jats:sup>2<\/jats:sup> = 17.6%; allele C vs. A: OR = 1.38, 95% CI = 1.04\u20131.82. P = 0.043 for heterogeneity, I<jats:sup>2<\/jats:sup> = 56.4%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Rs13181 in <jats:italic>ERCC2<\/jats:italic> gene might be associated with oral leukoplakia risk.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-13-594","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T06:01:02Z","timestamp":1386828062000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association between polymorphisms in ERCC2 gene and oral cancer risk: evidence from a meta-analysis"],"prefix":"10.1186","volume":"13","author":[{"given":"Enjiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuexin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changfu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,12]]},"reference":[{"key":"4218_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322\/caac.20107.","journal-title":"CA Cancer J Clin"},{"key":"4218_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-3284-4-1","volume":"4","author":"DM Saman","year":"2012","unstructured":"Saman DM: A review of the epidemiology of oral and pharyngeal carcinoma: update. Head Neck Oncol. 2012, 4: 1-10.1186\/1758-3284-4-1.","journal-title":"Head Neck Oncol"},{"key":"4218_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1600-0714.1992.tb00970.x","volume":"21","author":"PC Gupta","year":"1992","unstructured":"Gupta PC, Mehta FS, Pindborg JJ, Bhonsle RB, Murti PR, Daftary DK, Aghi MB: Primary prevention trial of oral cancer in india: a 10-year follow-up study. J Oral Pathol Med. 1992, 21: 433-439. 10.1111\/j.1600-0714.1992.tb00970.x.","journal-title":"J Oral Pathol Med"},{"key":"4218_CR4","first-page":"465","volume":"7","author":"L Cheng","year":"1998","unstructured":"Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q: Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1998, 7: 465-468.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4218_CR5","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/carcin\/21.8.1527","volume":"21","author":"L Cheng","year":"2000","unstructured":"Cheng L, Spitz MR, Hong WK, Wei Q: Reduced expression levels of nucleotide excision repair genes in lung cancer: a case\u2013control analysis. Carcinogenesis. 2000, 21: 1527-1530. 10.1093\/carcin\/21.8.1527.","journal-title":"Carcinogenesis"},{"key":"4218_CR6","first-page":"283","volume":"14","author":"MC Poirier","year":"2012","unstructured":"Poirier MC: Chemical-induced DNA damage and human cancer risk. Discov Med. 2012, 14: 283-288.","journal-title":"Discov Med"},{"key":"4218_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4419-9967-2_1","volume":"754","author":"B Jin","year":"2013","unstructured":"Jin B, Robertson KD: DNA methyltransferases, DNA damagen repair, and cancer. Adv Exp Med Biol. 2013, 754: 3-29. 10.1007\/978-1-4419-9967-2_1.","journal-title":"Adv Exp Med Biol"},{"key":"4218_CR8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/jnci\/92.11.874","volume":"92","author":"M Berwick","year":"2000","unstructured":"Berwick M, Vineis P: Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000, 92: 874-897. 10.1093\/jnci\/92.11.874.","journal-title":"J Natl Cancer Inst"},{"key":"4218_CR9","volume-title":"DNA Repair and Mutagenesis, Chapters 1\u20137","author":"EC Friedberg","year":"1995","unstructured":"Friedberg EC, Walker GC, Siede W: DNA Repair and Mutagenesis, Chapters 1\u20137. 1995, Washington, DC: ASM Press"},{"key":"4218_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.oraloncology.2010.08.009","volume":"46","author":"MB Mahimkar","year":"2010","unstructured":"Mahimkar MB, Samant TA, Kannan S, Patil T: Influence of genetic polymorphisms on frequency of micronucleated buccal epithelial cells in leukoplakia patients. Oral Oncol. 2010, 46: 761-766. 10.1016\/j.oraloncology.2010.08.009.","journal-title":"Oral Oncol"},{"key":"4218_CR11","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/1078-0432.CCR-06-1911","volume":"13","author":"Y Wang","year":"2007","unstructured":"Wang Y, Spitz MR, Lee JJ, Huang M, Lippman SM, Wu X: Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007, 13: 3753-3758. 10.1158\/1078-0432.CCR-06-1911.","journal-title":"Clin Cancer Res"},{"key":"4218_CR12","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1002\/ijc.22547","volume":"120","author":"M Majumder","year":"2007","unstructured":"Majumder M, Sikdar N, Ghosh S, Roy B: Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer. 2007, 120: 2148-2156. 10.1002\/ijc.22547.","journal-title":"Int J Cancer"},{"key":"4218_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijheh.2005.06.002","volume":"209","author":"S Kietthubthew","year":"2006","unstructured":"Kietthubthew S, Sriplung H, Au WW, Ishida T: Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health. 2006, 209: 21-29. 10.1016\/j.ijheh.2005.06.002.","journal-title":"Int J Hyg Environ Health"},{"key":"4218_CR14","first-page":"294","volume":"50","author":"DT Bau","year":"2007","unstructured":"Bau DT, Tsai MH, Huang CY, Lee CC, Tseng HC, Lo YL, Tsai Y, Tsai FJ: Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chin J Physiol. 2007, 50: 294-300.","journal-title":"Chin J Physiol"},{"key":"4218_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.oraloncology.2005.08.010","volume":"42","author":"S Ramachandran","year":"2006","unstructured":"Ramachandran S, Ramadas K, Hariharan R, Rejnish Kumar R, Radhakrishna Pillai M: Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 2006, 42: 350-362. 10.1016\/j.oraloncology.2005.08.010.","journal-title":"Oral Oncol"},{"key":"4218_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF02532251","volume":"21","author":"H Akaike","year":"1969","unstructured":"Akaike H: Fitting autoregressive models for prediction. Ann Inst Stat Math. 1969, 21: 243-247. 10.1007\/BF02532251.","journal-title":"Ann Inst Stat Math"},{"key":"4218_CR17","doi-asserted-by":"publisher","first-page":"7980","DOI":"10.1128\/MCB.20.21.7980-7990.2000","volume":"20","author":"IU De Silva","year":"2000","unstructured":"De Silva IU, McHugh PJ, Clingen PH, Hartley JA: Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol. 2000, 20: 7980-7990. 10.1128\/MCB.20.21.7980-7990.2000.","journal-title":"Mol Cell Biol"},{"key":"4218_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0027-5107(99)00020-2","volume":"424","author":"E Braithwaite","year":"1999","unstructured":"Braithwaite E, Wu X, Wang Z: Repair of DNA lesions: mechanisms and relative repair efficiencies. Mutat Res. 1999, 424: 207-219. 10.1016\/S0027-5107(99)00020-2.","journal-title":"Mutat Res"},{"key":"4218_CR19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1124\/mol.52.5.815","volume":"52","author":"ZP Chen","year":"1997","unstructured":"Chen ZP, Malapetsa A, McQuillan A, Marcantonio D, Bello V, Mohr G, Remack J, Brent TP, Panasci LC: Evidence for nucleotide excision repair as a modifying factor of O6-methylguanine-DNA methyltransferase-mediated innate chloroethylnitrosourea resistance in human tumor cell lines. Mol Pharmacol. 1997, 52: 815-820. 10.1124\/mol.52.5.815.","journal-title":"Mol Pharmacol"},{"key":"4218_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/mutage\/17.6.463","volume":"17","author":"S Benhamou","year":"2002","unstructured":"Benhamou S, Sarasin A: ERCC2\/XPD gene polymorphisms and cancer risk. Mutagenesis. 2002, 17: 463-469. 10.1093\/mutage\/17.6.463.","journal-title":"Mutagenesis"},{"key":"4218_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","volume":"21","author":"RW Lunn","year":"2000","unstructured":"Lunn RW, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA: XPD polymorphisms: effect on DNA repair proficiency. Carcinogenesis. 2000, 21: 551-555. 10.1093\/carcin\/21.4.551.","journal-title":"Carcinogenesis"},{"key":"4218_CR22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/carcin\/23.4.599","volume":"23","author":"SM Hou","year":"2002","unstructured":"Hou SM, Falt S, Angelini S, Yang K, Nyberg F, Lambert B, Hemminki K: The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis. 2002, 23: 599-603. 10.1093\/carcin\/23.4.599.","journal-title":"Carcinogenesis"},{"key":"4218_CR23","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1289\/ehp.6632","volume":"111","author":"WW Au","year":"2003","unstructured":"Au WW, Salama SA, Sierra-Torres CH: Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect. 2003, 111: 1843-1850. 10.1289\/ehp.6632.","journal-title":"Environ Health Perspect"},{"key":"4218_CR24","first-page":"1354","volume":"61","author":"MR Spitz","year":"2001","unstructured":"Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q: Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001, 61: 1354-1357.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-594\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:30:37Z","timestamp":1630549837000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4218"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-594","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"7 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"594"}}